Usa covid-19 recommendations vaccine Usa

FDA committee approves Moderna COVID vaccine for kids 6 to 17

Reading now: 585

In a move poised to bring a second COVID-19 vaccine to the market for US kids, the Food and Drug Administration (FDA) advisory committee today approved the Moderna vaccine for children ages 6 through 17 years.The vote by the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) today precedes its deliberations tomorrow on EUA modifications for Moderna and Pfizer-BioNTech mRNA vaccines for the youngest children yet to receive vaccine eligibility, those ages 6 months to age 5.

If approved, nearly all Americans would finally be eligible for COVID-19 vaccination.The votes this week come as more parts of the country move into the high community-transmission category and more transmissible BA.4 and BA.5 Omicron subvariants expand their reach.Concerns about Omicron protectionDuring today's discussions, VRBPAC weighed the benefits and risks of the two-shot vaccine series at a dose based on age: the 100-micogram adult dose for adolescents ages 12 through 17 and a 50-microgram dose for children ages 6 through 11.

The votes passed unanimously for use of the vaccine in both age groups.During the discussions, many members said they were comfortable with the data on the vaccine, and that approval of a second mRNA vaccine for kids provides parents another choice and greater access.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News